Imap

Fluspirilene, the active ingredient in Imap, is a typical antipsychotic presented as an intramuscular injection for intramuscular use. It is employed in the management of schizophrenia, helping to control psychotic symptoms in adult patients.

GNH USA supplies Imap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with rigorous quality assurance and regulatory compliance. Our distribution network ensures timely and consistent delivery across the EU, Asia and the Americas, adhering to cold‑chain requirements for injectable products.

Fluspirilene is a typical antipsychotic that acts on dopamine pathways to treat schizophrenia and related psychotic disorders.

Schizophrenia (maintenance therapy): helps maintain long‑term control of psychotic symptoms. Schizophrenia (acute episodes): reduces severity of acute psychotic manifestations. Schizophrenia (adjunctive therapy): used when oral antipsychotics are unsuitable or poorly tolerated.

Fluspirilene may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Extrapyramidal symptoms (e.g., tremor, rigidity) - Sedation or drowsiness - Dry mouth - Constipation

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hypotension or cardiac arrhythmia

When prescribing Fluspirilene, clinicians should consider several safety aspects.

Cardiovascular monitoring: assess baseline blood pressure and heart rhythm. Metabolic assessment: monitor weight, glucose, and lipid levels. Neurological evaluation: watch for early signs of extrapyramidal symptoms. Pregnancy and lactation: weigh potential risks against benefits. Drug interactions: review concomitant medications for additive CNS depression. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Fluspirilene can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines): risk of profound sedation. - Antihypertensives: may cause excessive hypotension. - Drugs that prolong QT interval: increase risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may mask extrapyramidal symptoms. - CYP450 inhibitors or inducers: can alter plasma levels of Fluspirilene.